NR4A1 and breast carcinoma: These results are similar to what was published by Fedele et al., who showed that INPP4B protein expression loss was associated with high clinical grade and loss of hormone receptors and occurred most commonly in aggressive basal-like breast carcinomas, including PTEN-null tumors [6].